167 related articles for article (PubMed ID: 37243271)
21. Pharmacologic Inhibition of Nedd8 Activation Enzyme Exposes CD4-Induced Epitopes within Env on Cells Expressing HIV-1.
Tokarev A; Stoneham C; Lewinski MK; Mukim A; Deshmukh S; Vollbrecht T; Spina CA; Guatelli J
J Virol; 2015 Dec; 90(5):2486-502. PubMed ID: 26676780
[TBL] [Abstract][Full Text] [Related]
22. The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity.
Marchitto L; Richard J; Prévost J; Tauzin A; Yang D; Chiu T; Chen HC; Díaz-Salinas MA; Nayrac M; Benlarbi M; Beaudoin-Bussières G; Anand SP; Dionne K; Bélanger É; Chatterjee D; Medjahed H; Bourassa C; Tolbert WD; Hahn BH; Munro JB; Pazgier M; Smith AB; Finzi A
bioRxiv; 2024 Jun; ():. PubMed ID: 38895270
[TBL] [Abstract][Full Text] [Related]
23. Unlocking HIV-1 Env: implications for antibody attack.
Richard J; Ding S; Finzi A
AIDS Res Ther; 2017 Sep; 14(1):42. PubMed ID: 28893275
[TBL] [Abstract][Full Text] [Related]
24. Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound.
Anang S; Richard J; Bourassa C; Goyette G; Chiu TJ; Chen HC; Smith AB; Madani N; Finzi A; Sodroski J
J Virol; 2022 Sep; 96(17):e0063622. PubMed ID: 35980207
[TBL] [Abstract][Full Text] [Related]
25. Modulating HIV-1 envelope glycoprotein conformation to decrease the HIV-1 reservoir.
Rajashekar JK; Richard J; Beloor J; Prévost J; Anand SP; Beaudoin-Bussières G; Shan L; Herndler-Brandstetter D; Gendron-Lepage G; Medjahed H; Bourassa C; Gaudette F; Ullah I; Symmes K; Peric A; Lindemuth E; Bibollet-Ruche F; Park J; Chen HC; Kaufmann DE; Hahn BH; Sodroski J; Pazgier M; Flavell RA; Smith AB; Finzi A; Kumar P
Cell Host Microbe; 2021 Jun; 29(6):904-916.e6. PubMed ID: 34019804
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical Isolates.
Matsumoto K; Kuwata T; Tolbert WD; Richard J; Ding S; Prévost J; Takahama S; Judicate GP; Ueno T; Nakata H; Kobayakawa T; Tsuji K; Tamamura H; Smith AB; Pazgier M; Finzi A; Matsushita S
J Virol; 2023 Jan; 97(1):e0163822. PubMed ID: 36511698
[TBL] [Abstract][Full Text] [Related]
27. Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity.
Alsahafi N; Ding S; Richard J; Markle T; Brassard N; Walker B; Lewis GK; Kaufmann DE; Brockman MA; Finzi A
J Virol; 2015 Dec; 90(6):2993-3002. PubMed ID: 26719277
[TBL] [Abstract][Full Text] [Related]
28. Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses.
Prévost J; Zoubchenok D; Richard J; Veillette M; Pacheco B; Coutu M; Brassard N; Parsons MS; Ruxrungtham K; Bunupuradah T; Tovanabutra S; Hwang KK; Moody MA; Haynes BF; Bonsignori M; Sodroski J; Kaufmann DE; Shaw GM; Chenine AL; Finzi A
J Virol; 2017 Apr; 91(7):. PubMed ID: 28100618
[TBL] [Abstract][Full Text] [Related]
29. Role of HIV-1 Envelope Glycoproteins Conformation and Accessory Proteins on ADCC Responses.
Veillette M; Richard J; Pazgier M; Lewis GK; Parsons MS; Finzi A
Curr HIV Res; 2016; 14(1):9-23. PubMed ID: 26310828
[TBL] [Abstract][Full Text] [Related]
30. HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2.
Pham TN; Lukhele S; Hajjar F; Routy JP; Cohen ÉA
Retrovirology; 2014 Feb; 11():15. PubMed ID: 24498878
[TBL] [Abstract][Full Text] [Related]
31. Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Primates Neutralize Primary Human Immunodeficiency Viruses (HIV-1) Sensitized by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Easterhoff D; Bradley T; Luo K; Williams WB; Liao HX; Moody MA; Phad GE; Vázquez Bernat N; Melillo B; Santra S; Smith AB; Karlsson Hedestam GB; Haynes B; Sodroski J
J Virol; 2016 May; 90(10):5031-5046. PubMed ID: 26962221
[TBL] [Abstract][Full Text] [Related]
32. Detection of the HIV-1 Accessory Proteins Nef and Vpu by Flow Cytometry Represents a New Tool to Study Their Functional Interplay within a Single Infected CD4
Prévost J; Richard J; Gasser R; Medjahed H; Kirchhoff F; Hahn BH; Kappes JC; Ochsenbauer C; Duerr R; Finzi A
J Virol; 2022 Mar; 96(6):e0192921. PubMed ID: 35080425
[TBL] [Abstract][Full Text] [Related]
33. CD4 mimetics sensitize HIV-1-infected cells to ADCC.
Richard J; Veillette M; Brassard N; Iyer SS; Roger M; Martin L; Pazgier M; Schön A; Freire E; Routy JP; Smith AB; Park J; Jones DM; Courter JR; Melillo BN; Kaufmann DE; Hahn BH; Permar SR; Haynes BF; Madani N; Sodroski JG; Finzi A
Proc Natl Acad Sci U S A; 2015 May; 112(20):E2687-94. PubMed ID: 25941367
[TBL] [Abstract][Full Text] [Related]
34. Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated Cytotoxicity.
Richard J; Veillette M; Ding S; Zoubchenok D; Alsahafi N; Coutu M; Brassard N; Park J; Courter JR; Melillo B; Smith AB; Shaw GM; Hahn BH; Sodroski J; Kaufmann DE; Finzi A
EBioMedicine; 2016 Jan; 3():122-134. PubMed ID: 26870823
[TBL] [Abstract][Full Text] [Related]
35. Antibody-dependent cellular cytotoxicity targeting CD4-inducible epitopes predicts mortality in HIV-infected infants.
Naiman NE; Slyker J; Richardson BA; John-Stewart G; Nduati R; Overbaugh JM
EBioMedicine; 2019 Sep; 47():257-268. PubMed ID: 31501077
[TBL] [Abstract][Full Text] [Related]
36. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
Shen X; Bogers WM; Yates NL; Ferrari G; Dey AK; Williams WT; Jaeger FH; Wiehe K; Sawant S; Alam SM; LaBranche CC; Montefiori DC; Martin L; Srivastava I; Heeney J; Barnett SW; Tomaras GD
J Virol; 2017 Oct; 91(19):. PubMed ID: 28490585
[TBL] [Abstract][Full Text] [Related]
37. Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infection.
Acharya P; Tolbert WD; Gohain N; Wu X; Yu L; Liu T; Huang W; Huang CC; Kwon YD; Louder RK; Luongo TS; McLellan JS; Pancera M; Yang Y; Zhang B; Flinko R; Foulke JS; Sajadi MM; Kamin-Lewis R; Robinson JE; Martin L; Kwong PD; Guan Y; DeVico AL; Lewis GK; Pazgier M
J Virol; 2014 Nov; 88(21):12895-906. PubMed ID: 25165110
[TBL] [Abstract][Full Text] [Related]
38. CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies.
Madani N; Princiotto AM; Schön A; LaLonde J; Feng Y; Freire E; Park J; Courter JR; Jones DM; Robinson J; Liao HX; Moody MA; Permar S; Haynes B; Smith AB; Wyatt R; Sodroski J
J Virol; 2014 Jun; 88(12):6542-55. PubMed ID: 24696475
[TBL] [Abstract][Full Text] [Related]
39. Characterization of antibody-dependent cellular cytotoxicity induced by the plasma from persons living with HIV-1 based on target cells with or without CD4 molecules.
Ding Y; Kong D; Li D; Zhang Y; Hong K; Liang H; Ma L
Microbes Infect; 2021; 23(4-5):104805. PubMed ID: 33711449
[TBL] [Abstract][Full Text] [Related]
40. VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120.
Smith SA; Burton SL; Kilembe W; Lakhi S; Karita E; Price M; Allen S; Derdeyn CA
Front Immunol; 2018; 9():3163. PubMed ID: 30697215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
